• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Best Practices for Postmarket Drug Safety Surveillance: FDA Seeks Comments

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 06, 2019 at 05:22: PM
via The US Food and Drug Administration (FDA) on Wednesday released for public comment a draft version of best practices in drug and biologic postmarket safety surveillance.

article source
 




Top Bottom
Back
Quote